Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | AROA BIOSURGERY LIMITED: Change in substantial holding | 1 | ASX | ||
AROA BIOSURGERY Aktie jetzt für 0€ handeln | |||||
Do | AROA BIOSURGERY LIMITED: Notification of Quarterly Results Webinar | 1 | ASX | ||
Mi | AROA BIOSURGERY LIMITED: Notification of cessation of securities - ARX | 1 | ASX | ||
23.09. | AROA BIOSURGERY LIMITED: Change of Director's Interest Notice - BW | - | ASX | ||
23.09. | AROA BIOSURGERY LIMITED: Notification regarding unquoted securities - ARX | - | ASX | ||
10.09. | Aroa to hit right note as US skin substitute rules set for change | 1 | Stockhead | ||
20.08. | AROA BIOSURGERY LIMITED: Results of Annual General Meeting | - | ASX | ||
20.08. | AROA BIOSURGERY LIMITED: CEO Presentation - AGM | - | ASX | ||
20.08. | AROA BIOSURGERY LIMITED: Chairman's Address - AGM | - | ASX | ||
06.08. | AROA BIOSURGERY LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
29.07. | AROA BIOSURGERY LIMITED: Investor Presentation | - | ASX | ||
29.07. | AROA BIOSURGERY LIMITED: June 2025 Quarterly Report and Appendix 4C | - | ASX | ||
25.07. | AROA BIOSURGERY LIMITED: Change of Director's Interest Notice - PM | - | ASX | ||
25.07. | AROA BIOSURGERY LIMITED: Change of Director's Interest Notice - JP | - | ASX | ||
25.07. | AROA BIOSURGERY LIMITED: Change of Director's Interest Notice - JM | - | ASX | ||
25.07. | AROA BIOSURGERY LIMITED: Change of Director's Interest Notice - BW | - | ASX | ||
25.07. | AROA BIOSURGERY LIMITED: Notification of cessation of securities - ARX | - | ASX | ||
22.07. | AROA BIOSURGERY LIMITED: Notification of Quarterly Results Webinar | - | ASX | ||
11.07. | AROA BIOSURGERY LIMITED: Notification of cessation of securities - ARX | - | ASX | ||
10.07. | AROA BIOSURGERY LIMITED: Notification of Cessation of Securities - Correction | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 87,95 | +0,11 % | BioNTech Aktie zeigt Stärke: Es wird spannend! | Seit dem letzten 4investors.de-Chartcheck zur BioNTech Aktie hat sich einiges getan. Der Aktienkurs des Mainzer Biotech-Konzerns ist an der NASDAQ um rund 9 Dollar gestiegen, hat die 20- und 50-Tage-Linie... ► Artikel lesen | |
EVOTEC | 6,698 | -0,86 % | Evotec Aktie: Strohfeuer oder klappt es diesmal? | Die Evotec Aktie zeigt Stärke - aber diesmal auch für eine längere Zeit? Seit dem 26. September hat sich die TecDAX-notierte Biotech-Aktie von 5,882 Euro um mehr als einen Euro verteuert. Am gestrigen... ► Artikel lesen | |
CUREVAC | 4,592 | -0,82 % | CureVac SCHOCKIERT Anleger: Könnte die Aktie am Montag komplett einbrechen - Experten warnen!!! | ||
MODERNA | 22,965 | -3,45 % | Moderna, Inc.: Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress | mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety... ► Artikel lesen | |
NOVAVAX | 7,147 | -0,31 % | Novavax hands over Nuvaxovid marketing rights to Sanofi in the EU | ||
HEIDELBERG PHARMA | 3,090 | +0,65 % | EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma gibt Aktualisierung der Prognose bekannt | EQS-Ad-hoc: Heidelberg Pharma AG / Schlagwort(e): Prognoseänderung
Heidelberg Pharma AG gibt Aktualisierung der Prognose bekannt
06.10.2025 / 15:58 CET/CEST
Veröffentlichung einer... ► Artikel lesen | |
INOVIO PHARMACEUTICALS | 2,260 | +1,80 % | INOVIO Pharmaceuticals, Inc.: INOVIO Reports Inducement Grant Under Inducement Plan | PLYMOUTH MEETING, Pa., Oct. 2, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help... ► Artikel lesen | |
SCORPIUS | 0,072 | 0,00 % | Scorpius Holdings sichert sich neue Finanzierung und Option auf bis zu 5 Mio. US-Dollar | ||
TREVENA | 2,280 | -40,00 % | Hollywood Changemaker Oliver Trevena Joins Little Kitchen Academy as Investor | LOS ANGELES, CA / ACCESS Newswire / August 21, 2025 / Little Kitchen Academy (LKA), the premier Montessori-inspired cooking academy for children and teens ages 3-18, is proud to announce that Oliver... ► Artikel lesen | |
DYNAVAX | 8,684 | +1,19 % | Dynavax Technologies: Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile | At all doses and formulations evaluated in Part 1 of the trial, Z-1018 was well-tolerated and demonstrated a favorable tolerability profile, including lower solicited... ► Artikel lesen | |
BIOMARIN PHARMACEUTICAL | 44,980 | -0,16 % | 6 Analysts Assess BioMarin Pharmaceutical: What You Need To Know | ||
VAXART | 0,270 | -3,91 % | Vaxart, Inc. - 8-K, Current Report | ||
IBIO | 0,690 | +1,47 % | iBio, Inc.: iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update | SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June... ► Artikel lesen | |
ARBUTUS BIOPHARMA | 3,560 | +0,45 % | Arbutus Biopharma Corp - 8-K, Current Report | ||
CELLECTAR BIOSCIENCES | 4,630 | -2,94 % | Cellectar Biosciences, Inc.: Cellectar Biosciences Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) ... | Following Scientific Advice and Guidance from Scientific Advice Working Party (SAWP) of EMA, Submission of CMA Application for Iopofosine I 131 as a Treatment for Refractory (post-BTKi) WM Expected... ► Artikel lesen |